Featured
Read our handpicked blogs, curated for you.
|
AI BankingYour organization runs thousands of AI models across fraud detection, credit scoring, and customer journeys.…
|
The Enforcement Horizon: August 2, 2026The industry consensus is dominated by the EU AI Act. As of mid-2026, AI systems…
|
The 2026 Industry Consensus: From Policies to EnforcementThe prevailing consensus among global Tier-1 banks is the…
Recent releases
|
How CMOs Can Use Marketing Automation to Improve Doctor Engagement in Tier 2 and 3 India
For CMOs and Digital Brand Managers in the Indian pharmaceutical industry, the conversation has shifted. It’s no longer about reach; it’s about resonance. Especially in Tier 2 and 3 cities, where the…
|
A CMO's Guide: Why Traditional Pharma Digital Marketing in India Is Dying (And What to Do About It)
The era of field-rep-only marketing is over. Now, even the most established pharmaceutical giants are struggling to keep up with the pace of change. What once worked (rep visits, CME events, reminder…
|
What Is the Uniform Code for Pharmaceutical Marketing Practices UCPMP 2024?
The Uniform Code for Pharmaceutical Marketing Practices (UCPMP) 2024 marks a pivotal shift in how pharma companies engage in promotions and communications. Issued by India’s Department of…
|
Compliance-Ready Digital Marketing in Pharma: How to Stay Safe and Scale
In the tightly regulated world of pharmaceuticals, marketing isn't just about reach and recall. It's about responsibility. With the introduction of UCPMP 2024, digital marketing in pharma…
